Healthcare provider profile · identity verified

Zoe D Berna, MD

Family Practice · FORT BRAGG, CA · NPI 1740377118

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	520	167
Lisinopril	Lisinopril	335	102
Levothyroxine Sodium	Levothyroxine Sodium	331	103
Amlodipine Besylate	Amlodipine Besylate	307	96
Losartan Potassium	Losartan Potassium	305	95
Metoprolol Succinate	Metoprolol Succinate	237	69
Gabapentin	Gabapentin	197	56
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	195	36
Omeprazole	Omeprazole	165	52
Eliquis	Apixaban	151	34
Tramadol Hcl	Tramadol Hcl	142	30
Hydrochlorothiazide	Hydrochlorothiazide	137	44
Metformin Hcl Er	Metformin Hcl	136	39
Trazodone Hcl	Trazodone Hcl	129	38
Albuterol Sulfate Hfa	Albuterol Sulfate	104	41
Tamsulosin Hcl	Tamsulosin Hcl	103	32
Famotidine	Famotidine	99	31
Alendronate Sodium	Alendronate Sodium	92	23
Furosemide	Furosemide	92	33
Pantoprazole Sodium	Pantoprazole Sodium	88	26
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	88	12
Escitalopram Oxalate	Escitalopram Oxalate	87	26
Metformin Hcl	Metformin Hcl	85	23
Rosuvastatin Calcium	Rosuvastatin Calcium	81	22
Potassium Chloride	Potassium Chloride	79	29
Simvastatin	Simvastatin	77	26
Allopurinol	Allopurinol	73	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	72	18
Zolpidem Tartrate	Zolpidem Tartrate	69	20
Benazepril Hcl	Benazepril Hcl	68	19
Ibuprofen	Ibuprofen	68	28
Pravastatin Sodium	Pravastatin Sodium	67	20
Sertraline Hcl	Sertraline Hcl	67	23
Carvedilol	Carvedilol	63	16
Duloxetine Hcl	Duloxetine Hcl	63	24
Fluticasone Propionate	Fluticasone Propionate	60	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	18
Spironolactone	Spironolactone	53	18
Montelukast Sodium	Montelukast Sodium	52	17
Baclofen	Baclofen	48	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	48	16
Estradiol	Estradiol	48	17
Glimepiride	Glimepiride	48	13
Lorazepam	Lorazepam	45	18
Donepezil Hcl	Donepezil Hcl	44	12
Fluoxetine Hcl	Fluoxetine Hcl	44	12
Clopidogrel	Clopidogrel Bisulfate	43	12
Ozempic	Semaglutide	42	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	11
Quetiapine Fumarate	Quetiapine Fumarate	37	13
Ventolin Hfa	Albuterol Sulfate	36	12
Xarelto	Rivaroxaban	36	suppressed
Meloxicam	Meloxicam	35	13
Synthroid	Levothyroxine Sodium	35	13
Valacyclovir	Valacyclovir Hcl	33	11
Clonazepam	Clonazepam	32	suppressed
Finasteride	Finasteride	32	12
Jardiance	Empagliflozin	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Alprazolam	Alprazolam	29	15
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	11
Myrbetriq	Mirabegron	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	24	suppressed
Glipizide	Glipizide	23	suppressed
Levemir Flexpen	Insulin Detemir	23	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Celecoxib	Celecoxib	21	suppressed
Diazepam	Diazepam	21	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Amoxicillin	Amoxicillin	19	11
Memantine Hcl	Memantine Hcl	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Acyclovir	Acyclovir	17	11
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Cephalexin	Cephalexin	16	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	14
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Atenolol	Atenolol	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Gemtesa	Vibegron	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Nystatin	Nystatin	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Prempro	Estrogen,con/M-Progest Acet	13	suppressed
Risperidone	Risperidone	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Minoxidil	Minoxidil	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Primidone	Primidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error